Liabilities of COSCIENS Biopharma Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD and CAD
Summary
COSCIENS Biopharma Inc. quarterly Liabilities in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • COSCIENS Biopharma Inc. Liabilities for the quarter ending 31 Dec 2024 was $21,909,000, a 708% increase year-over-year.
COSCIENS Biopharma Inc. quarterly Liabilities in CAD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • COSCIENS Biopharma Inc. Liabilities for the quarter ending 31 Dec 2023 was CA$3,591,000, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)
Liabilities, Quarterly (CAD)
Liabilities, YoY Quarterly Change (%)

COSCIENS Biopharma Inc. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $21,909,000 +$19,199,000 +708% 31 Dec 2024 20-F 09 Apr 2025 2024 FY
Q3 2024 $23,755,000 +$7,547,000 +47% 30 Sep 2024 6-K 12 Nov 2024 2024 Q3
Q2 2024 $23,818,000 +$6,414,000 +37% 30 Jun 2024 6-K 13 Aug 2024 2024 Q2
Q1 2024 $18,822,000 -$1,252,000 -6.2% 31 Mar 2024 6-K 16 May 2024 2024 Q1
Q4 2023 $2,710,000 -$1,308,000 -33% 31 Dec 2023 20-F 09 Apr 2025 2024 FY
Q3 2023 $16,208,000 -$980,000 -5.7% 30 Sep 2023 6-K 09 Nov 2023 2023 Q3
Q2 2023 $17,404,000 -$127,000 -0.72% 30 Jun 2023 6-K 09 Aug 2023 2023 Q2
Q1 2023 $20,074,000 -$3,111,000 -13% 31 Mar 2023 6-K 09 May 2023 2023 Q1
Q4 2022 $4,018,000 -$23,098,000 -85% 31 Dec 2022 20-F 09 Apr 2025 2024 FY
Q3 2022 $17,188,000 -$4,928,000 -22% 30 Sep 2022 6-K 03 Nov 2022 2022 Q3
Q2 2022 $17,531,000 -$5,474,000 -24% 30 Jun 2022 6-K/A 04 Aug 2022 2022 Q2
Q1 2022 $23,185,000 +$345,000 +1.5% 31 Mar 2022 6-K 11 May 2022 2022 Q1
Q4 2021 $27,116,000 +$3,322,000 +14% 31 Dec 2021 20-F/A 15 Feb 2024 2022 FY
Q3 2021 $22,116,000 +$4,993,000 +29% 30 Sep 2021 6-K 04 Nov 2021 2021 Q3
Q2 2021 $23,005,000 +$6,267,000 +37% 30 Jun 2021 6-K 05 Aug 2021 2021 Q2
Q1 2021 $22,840,000 +$4,886,000 +27% 31 Mar 2021 6-K 05 May 2021 2021 Q1
Q4 2020 $23,794,000 +$1,350,000 +6% 31 Dec 2020 20-F 29 Mar 2022 2021 FY
Q3 2020 $17,123,000 -$6,572,000 -28% 30 Sep 2020 6-K 05 Nov 2020 2020 Q3
Q2 2020 $16,738,000 -$7,041,000 -30% 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q1 2020 $17,954,000 31 Mar 2020 6-K/A 11 May 2020 2020 Q1
Q4 2019 $22,444,000 -$660,000 -2.9% 31 Dec 2019 40-F/A 29 Mar 2021 2020 FY
Q3 2019 $23,695,000 30 Sep 2019 6-K 07 Nov 2019 2019 Q3
Q2 2019 $23,779,000 30 Jun 2019 6-K 13 Aug 2019 2019 Q2
Q4 2018 $23,104,000 -$1,874,000 -7.5% 31 Dec 2018 20-F 31 Mar 2020 2019 FY
Q4 2017 $24,978,000 -$469,000 -1.8% 31 Dec 2017 20-F 01 Apr 2019 2018 FY
Q4 2016 $25,447,000 31 Dec 2016 20-F 28 Mar 2018 2017 FY

COSCIENS Biopharma Inc. Quarterly Liabilities (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 CA$3,591,000 -CA$1,854,000 -34% 31 Dec 2023 20-F 09 Apr 2025 2024 FY
Q4 2022 CA$5,445,000 31 Dec 2022 20-F 09 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.